Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Therapeutic Areas


There are various forms of diabetes (diabetes mellitus), with the commonest being type 1 and type 2 diabetes1. Elevated blood glucose levels are common to all types of diabetes. Blood glucose levels may be high due to a lack of the hormone insulin and/or a reduction in the effect of the hormone. Insulin regulates the amount of blood glucose entering the cells. It affects around 7.2 percent of adults in Germany, with most (around 90 percent) suffering from type 2 diabetes1.

Type 2 diabetes is a condition caused by a reduction in sensitivity to insulin (insulin resistance) and a decrease in insulin production due to a persistently high insulin requirement, which ultimately overwhelms the insulin-producing cells in the pancreas. It often develops slowly and was formerly associated mainly with older adults but now occurs increasingly in younger people and adolescents as well. Risk factors are genetic predisposition, being overweight, lack of exercise, an imbalanced diet and smoking.

Whilst in people with type 1 diabetes the absolute insulin deficiency is primarily treated with insulin, treatment of type 2 diabetes focuses initially on lifestyle changes such as increased exercise, a change in diet and weight normalisation to improve insulin resistance and reduce the insulin requirement. If these changes are not enough, drug therapies are available, often administered in the form of tablets. If blood glucose control is still insufficient, insulin may also need to be administered to people with type 2 diabetes.